An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections NOVIR
An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA Gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms Simultaneously.
Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL
Discussion between the organization and the community about this dataset.
You have built a more comprehensive database than those presented here? This is the time to share it!
You reused these data and published an article, a computer graphics, or an application? It's time to let you know! Reference your work in just a few clicks and increase your visibility.